miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapyRuth Rodríguez‐Barrueco(Institut d'Investigació Biomédica de Bellvitge), José M. Silva(Icahn School of Medicine at Mount Sinai)Genes & DevelopmentMarch 15, 201710.1101/gad.292318.116Cited by 90SaveCiteExport RISWatch citationsRelated PapersInhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR<sup>−</sup>/HER2<sup>+</sup>breast cancers|Genes & Development|2015|121A microRNA Cluster Controls Fat Cell Differentiation and Adipose Tissue Expansion By Regulating SNCG|Advanced Science|2021|18